Expressing support for the designation of September 2021 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

Bill 117 H.Res. 494, titled "Expressing support for the designation of September 2021 as 'Sickle Cell Disease Awareness Month," aims to raise awareness about sickle cell disease in the United States. The bill emphasizes the importance of educating communities about the disease, as well as the need for research, early detection methods, effective treatments, and preventative care programs.

Sickle cell disease is a genetic disorder that affects the red blood cells, causing them to become rigid and sickle-shaped. This can lead to various complications, including pain crises, organ damage, and increased risk of infections. It primarily affects African Americans, but can also impact individuals of Hispanic, Middle Eastern, Asian, and Mediterranean descent.

By designating September 2021 as "Sickle Cell Disease Awareness Month," the bill aims to shed light on the challenges faced by individuals living with the disease and their families. It also seeks to promote the importance of early detection and access to quality care for those affected by sickle cell disease. Overall, Bill 117 H.Res. 494 underscores the need for increased awareness, research, and support for individuals living with sickle cell disease in the United States. It highlights the importance of addressing the unique needs of this population and working towards improved outcomes and quality of life for those affected by the disease.